These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 20890423)
41. [Expression of survivin, p27 and PTEN in hepatocellular carcinoma and their clinical significances]. Huang AM; Ding Y; Liu JF; Gao LY; Zang SB; Chen SP Zhonghua Gan Zang Bing Za Zhi; 2008 Jan; 16(1):17-20. PubMed ID: 18226337 [TBL] [Abstract][Full Text] [Related]
42. Cyclin dependent kinase inhibitor p27(kip1) expression and subcellular localization in relation to cell proliferation in hepatocellualr carcinoma. Shehata MA; Nosseir HR; Nagy HM; Farouk G Egypt J Immunol; 2006; 13(1):115-30. PubMed ID: 17974156 [TBL] [Abstract][Full Text] [Related]
43. Immunohistochemically detected expression of p27(Kip1) and Skp2 predicts survival in patients with intrahepatic cholangiocarcinomas. Hashimoto N; Yachida S; Okano K; Wakabayashi H; Imaida K; Kurokohchi K; Masaki T; Kinoshita H; Tominaga M; Ajiki T; Ku Y; Okabayashi T; Hanazaki K; Hiroi M; Izumi S; Mano S; Okada S; Karasawa Y; Maeba T; Suzuki Y Ann Surg Oncol; 2009 Feb; 16(2):395-403. PubMed ID: 19034576 [TBL] [Abstract][Full Text] [Related]
44. Expression of Jun activation domain-binding protein 1 and p27 (Kip1) in thyroid medullary carcinoma. Ito Y; Yoshida H; Nakamura Y; Tomoda C; Uruno T; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Kuma K; Kakudo K; Miyauchi A Pathology; 2005 Jun; 37(3):216-9. PubMed ID: 16175894 [TBL] [Abstract][Full Text] [Related]
45. Decreased expression and prognostic role of cytoplasmic BRSK1 in human breast carcinoma: correlation with Jab1 stability and PI3K/Akt pathway. Wang H; Liu XB; Chen JH; Wang QQ; Chen JP; Xu JF; Sheng CY; Ni QC Exp Mol Pathol; 2014 Oct; 97(2):191-201. PubMed ID: 25036402 [TBL] [Abstract][Full Text] [Related]
46. Overexpression of Jun activation domain-binding protein 1 in nonsmall cell lung cancer and its significance in p27 expression and clinical features. Osoegawa A; Yoshino I; Kometani T; Yamaguchi M; Kameyama T; Yohena T; Maehara Y Cancer; 2006 Jul; 107(1):154-61. PubMed ID: 16721818 [TBL] [Abstract][Full Text] [Related]
47. MicroRNA-17 acts as a tumor chemosensitizer by targeting JAB1/CSN5 in triple-negative breast cancer. Wang S; Oh DY; Leventaki V; Drakos E; Zhang R; Sahin AA; Resetkova E; Edgerton ME; Wu W; Claret FX Cancer Lett; 2019 Nov; 465():12-23. PubMed ID: 31473252 [TBL] [Abstract][Full Text] [Related]
48. Immunohistochemical study of Skp2 and Jab1, two key molecules in the degradation of P27, in lung adenocarcinoma. Goto A; Niki T; Moriyama S; Funata N; Moriyama H; Nishimura Y; Tsuchida R; Kato JY; Fukayama M Pathol Int; 2004 Sep; 54(9):675-81. PubMed ID: 15363035 [TBL] [Abstract][Full Text] [Related]
49. Overexpression of JAB1 promotes malignant behavior and predicts poor prognosis in esophageal squamous cell carcinoma. Shen Q; Shang B; Jiang B; Wang Y; Wang Z; Chen G Thorac Cancer; 2020 Apr; 11(4):973-982. PubMed ID: 32064781 [TBL] [Abstract][Full Text] [Related]
50. Expression of p27(KIP1) and p21(WAF1/CIP1) in primary hepatocellular carcinoma: clinicopathologic correlation and survival analysis. Qin LF; Ng IO Hum Pathol; 2001 Aug; 32(8):778-84. PubMed ID: 11521219 [TBL] [Abstract][Full Text] [Related]
51. Phosphorylated p27Kip1 on Thr157 is an important prognosis in human hepatocellular carcinoma in vivo and in vitro. He S; Lu M; Xue W; Wang Y; Zhao Y; Gao S; Ke Q; Liu Y; Li P; Cui X; Cheng C; Shen A Med Oncol; 2011 Mar; 28(1):94-104. PubMed ID: 20108172 [TBL] [Abstract][Full Text] [Related]
52. CKS1B overexpression implicates clinical aggressiveness of hepatocellular carcinomas but not p27(Kip1) protein turnover: an independent prognosticator with potential p27 (Kip1)-independent oncogenic attributes? Huang CW; Lin CY; Huang HY; Liu HW; Chen YJ; Shih DF; Chen HY; Juan CC; Ker CG; Huang CY; Li CF; Shiue YL Ann Surg Oncol; 2010 Mar; 17(3):907-22. PubMed ID: 19866239 [TBL] [Abstract][Full Text] [Related]
53. CACYBP Enhances Cytoplasmic Retention of P27 Lian YF; Huang YL; Zhang YJ; Chen DM; Wang JL; Wei H; Bi YH; Jiang ZW; Li P; Chen MS; Huang YH Theranostics; 2019; 9(26):8392-8408. PubMed ID: 31754404 [TBL] [Abstract][Full Text] [Related]
54. Expression of Pirh2, a p27(Kip1) ubiquitin ligase, in hepatocellular carcinoma: correlation with p27(Kip1) and cell proliferation. Huang X; Qian X; Cheng C; He S; Sun L; Ke Q; Zhang L; Pan X; He F; Wang Q; Meng J; Ni R; Shen A Hum Pathol; 2011 Apr; 42(4):507-15. PubMed ID: 21236467 [TBL] [Abstract][Full Text] [Related]
55. Array-based comparative genomic hybridization reveals recurrent chromosomal aberrations and Jab1 as a potential target for 8q gain in hepatocellular carcinoma. Patil MA; Gütgemann I; Zhang J; Ho C; Cheung ST; Ginzinger D; Li R; Dykema KJ; So S; Fan ST; Kakar S; Furge KA; Büttner R; Chen X Carcinogenesis; 2005 Dec; 26(12):2050-7. PubMed ID: 16000397 [TBL] [Abstract][Full Text] [Related]
56. Early mitotic inhibitor-1, an anaphase-promoting complex/cyclosome inhibitor, can control tumor cell proliferation in hepatocellular carcinoma: correlation with Skp2 stability and degradation of p27(Kip1). Zhao Y; Tang Q; Ni R; Huang X; Wang Y; Lu C; Shen A; Wang Y; Li C; Yuan Q; Chen H; Cheng C; He S Hum Pathol; 2013 Mar; 44(3):365-73. PubMed ID: 22995332 [TBL] [Abstract][Full Text] [Related]
57. Prognostic significance of localized p27Kip1 and potential role of Jab1/CSN5 in pancreatic cancer. Fukumoto A; Ikeda N; Sho M; Tomoda K; Kanehiro H; Hisanaga M; Tsurui Y; Tsutsumi M; Kato JY; Nakajima Y Oncol Rep; 2004 Feb; 11(2):277-84. PubMed ID: 14719054 [TBL] [Abstract][Full Text] [Related]
58. [Expression and relationship of p27(kip1) and its related molecules Jab1 and CRM1 during proliferation of lymphoma cells U937]. Wang YC; Zhang DM; Shen AG; Lu JX; Shao XY; He S; Cheng C Zhonghua Zhong Liu Za Zhi; 2007 Sep; 29(9):657-61. PubMed ID: 18246793 [TBL] [Abstract][Full Text] [Related]
59. Molecular targeting of CSN5 in human hepatocellular carcinoma: a mechanism of therapeutic response. Lee YH; Judge AD; Seo D; Kitade M; Gómez-Quiroz LE; Ishikawa T; Andersen JB; Kim BK; Marquardt JU; Raggi C; Avital I; Conner EA; MacLachlan I; Factor VM; Thorgeirsson SS Oncogene; 2011 Oct; 30(40):4175-84. PubMed ID: 21499307 [TBL] [Abstract][Full Text] [Related]
60. Skp2 and Jab1 expression are associated with inverse expression of p27(KIP1) and poor prognosis in oral squamous cell carcinomas. Shintani S; Li C; Mihara M; Hino S; Nakashiro K; Hamakawa H Oncology; 2003; 65(4):355-62. PubMed ID: 14707456 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]